BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7790112)

  • 21. Identification of somatostatin and gastrin receptors on enterochromaffin-like cells from Mastomys gastric tumors.
    Reubi JC; Waser B; Horisberger U; Halter F; Soroka CJ; Kumar RR; Goldenring JR; Modlin IM
    Endocrinology; 1992 Jul; 131(1):166-72. PubMed ID: 1319317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of substance P binding sites in submucous plexus of guinea pig ileum, using whole-mount autoradiography.
    Burcher E; Bornstein JC
    Synapse; 1988; 2(3):232-9. PubMed ID: 2463691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Old and new peptide receptor targets in cancer: future directions.
    Reubi JC
    Recent Results Cancer Res; 2013; 194():567-76. PubMed ID: 22918784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Somatostatin receptor status in non-medullary thyroid carcinoma].
    Görges R; Kahaly G; Müller-Brand J; Mäcke H; Walgenbach S; Bruns C; Andreas J; Brandt-Mainz K; Bockisch A
    Nuklearmedizin; 1999; 38(1):15-23. PubMed ID: 9987777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.
    Reubi JC; Waser B; Laissue JA; Gebbers JO
    Cancer Res; 1996 Apr; 56(8):1922-31. PubMed ID: 8620515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease.
    Reubi JC; Mazzucchelli L; Laissue JA
    Gastroenterology; 1994 Apr; 106(4):951-9. PubMed ID: 8144000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder.
    Burcher E; Zeng XP; Strigas J; Shang F; Millard RJ; Moore KH
    J Urol; 2000 Jan; 163(1):331-7. PubMed ID: 10604385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location.
    Reubi JC; Waser B; Liu Q; Laissue JA; Schonbrunn A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3882-91. PubMed ID: 11061553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin receptors and breast cancer.
    van Eijck CH; Kwekkeboom DJ; Krenning EP
    Q J Nucl Med; 1998 Mar; 42(1):18-25. PubMed ID: 9646641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase.
    Jeurissen F; Kavelaars A; Korstjens M; Broeke D; Franklin RA; Gelfand EW; Heijnen CJ
    J Immunol; 1994 Mar; 152(6):2987-94. PubMed ID: 7511635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.
    Reubi JC
    J Nucl Med; 1995 Oct; 36(10):1825-35. PubMed ID: 7562050
    [No Abstract]   [Full Text] [Related]  

  • 32. Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung.
    Walsh DA; Salmon M; Featherstone R; Wharton J; Church MK; Polak JM
    Br J Pharmacol; 1994 Dec; 113(4):1407-15. PubMed ID: 7534186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin receptors in human renal cell carcinomas.
    Reubi JC; Kvols L
    Cancer Res; 1992 Nov; 52(21):6074-8. PubMed ID: 1394233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution and density of substance P receptors in the feline gastrointestinal tract using autoradiography.
    Rothstein RD; Johnson E; Ouyang A
    Gastroenterology; 1991 Jun; 100(6):1576-81. PubMed ID: 1708347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.
    John M; Meyerhof W; Richter D; Waser B; Schaer JC; Scherübl H; Boese-Landgraf J; Neuhaus P; Ziske C; Mölling K; Riecken EO; Reubi JC; Wiedenmann B
    Gut; 1996 Jan; 38(1):33-9. PubMed ID: 8566856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development.
    Bright FM; Byard RW; Vink R; Paterson DS
    Brain Res Bull; 2018 Mar; 137():319-328. PubMed ID: 29331576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin-receptor scintigraphy in primary breast cancer.
    van Eijck CH; Krenning EP; Bootsma A; Oei HY; van Pel R; Lindemans J; Jeekel J; Reubi JC; Lamberts SW
    Lancet; 1994 Mar; 343(8898):640-3. PubMed ID: 7906813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
    Ciucci A; Palma C; Manzini S; Werge TM
    Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.
    Kvols LK; Reubi JC; Horisberger U; Moertel CG; Rubin J; Charboneau JW
    Yale J Biol Med; 1992; 65(5):505-18; discussion 531-6. PubMed ID: 1364090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.